Precision bioactives — a new category
The healthy-aging actives brands can't buy anywhere else.
Trilliome makes precision bioactives — plant-derived molecules that steer the human gut microbiome with species-level precision. Active at milligrams, not grams. Shelf-stable without refrigeration. Formulable into capsules, drinks, bars or topicals.
Got a minute? I'd love to know what brought you here.
Healthspan brands face an impossible trade-off.
You shouldn't have to choose.
-
01
The actives with real biology are the hardest to work with
The microbes most tied to cognitive and metabolic health are strict anaerobes that die in manufacturing. Live probiotics need cold chains. Conventional prebiotics work only at 5–10 gram doses and feed bacteria indiscriminately.
-
02
The actives that are easy to formulate are commodities
Differentiation-free, claim-free, margin-thin.
-
03
So brands choose
Efficacy or formulability, science or simplicity. And the healthspan claim that would actually move the category stays out of reach.
The bacteria most closely linked to healthy aging cannot be put in a pill. They are already in you.
The first two outputs of an engine that keeps producing.
Precision gut-brain activator Shelf-stable · milligram-scale · any format Selectively induces a named four-species consortium of keystone gut bacteria — microbes whose benefits reach well beyond butyrate. Launches with gut-health claims; the gut–brain story follows as the evidence builds. Low-MW prebiotic fibre Water-soluble · metabolic-health path · lean GRAS A water-soluble prebiotic fibre that feeds the gut's short-chain fatty acid producers — with a metabolic-health claim path under active study.We don't make an ingredient. We make a category.
At Trilliome's core is Teroka — a closed loop between a wetlab engine that measures how the gut ecosystem responds, and a computational engine that learns from it. Together they teach us how to steer the microbiome with high specificity.
TRI-01 and TRI-04 are the first two outputs. The platform is repeatable, it compounds, and it's the company — ingredients are the beginning, not the boundary.
Donor-stool fermentation, ex-vivo human gut models. A mechanistic signal — the foundation for the human studies now planned, not a clinical outcome on its own. See the evidence →
Defining the category, in the open.
Our scientists write about what they're actually working on: the gut–brain axis, keystone species, and what "evidence" should mean for functional ingredients.
What's new — and where you'll find us.
Latest
Find us
Stay close to the science.
Occasional updates on the platform, the evidence, and the category — for formulators, partners, and investors.